Tectonic Therapeutic, Inc. (TECX)
20.75
+0.10
(+0.48%)
USD |
NASDAQ |
Oct 19, 13:18
Tectonic Therapeutic Price to Book Value : 1.783 for Oct. 19, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 16, 2026 | 1.774 |
| October 15, 2026 | 1.830 |
| October 14, 2026 | 1.801 |
| October 13, 2026 | 1.831 |
| October 12, 2026 | 1.920 |
| October 09, 2026 | 2.005 |
| October 08, 2026 | 1.955 |
| October 07, 2026 | 1.952 |
| October 06, 2026 | 1.926 |
| October 05, 2026 | 1.986 |
| October 02, 2026 | 1.937 |
| October 01, 2026 | 1.948 |
| September 30, 2026 | 2.001 |
| September 29, 2026 | 2.006 |
| September 28, 2026 | 2.020 |
| September 25, 2026 | 2.034 |
| September 24, 2026 | 2.073 |
| September 23, 2026 | 2.146 |
| September 22, 2026 | 2.277 |
| September 21, 2026 | 2.288 |
| September 18, 2026 | 2.320 |
| September 17, 2026 | 2.338 |
| September 16, 2026 | 2.398 |
| September 15, 2026 | 2.450 |
| September 14, 2026 | 2.553 |
| Date | Value |
|---|---|
| September 11, 2026 | 2.496 |
| September 10, 2026 | 2.458 |
| September 09, 2026 | 2.619 |
| September 08, 2026 | 2.612 |
| September 04, 2026 | 2.642 |
| September 03, 2026 | 2.571 |
| September 02, 2026 | 2.611 |
| September 01, 2026 | 2.683 |
| August 31, 2026 | 2.573 |
| August 28, 2026 | 3.061 |
| August 27, 2026 | 3.154 |
| August 26, 2026 | 3.091 |
| August 25, 2026 | 3.240 |
| August 24, 2026 | 3.134 |
| August 21, 2026 | 3.234 |
| August 20, 2026 | 3.098 |
| August 19, 2026 | 3.183 |
| August 18, 2026 | 3.146 |
| August 17, 2026 | 2.909 |
| August 14, 2026 | 3.000 |
| August 13, 2026 | 2.920 |
| August 12, 2026 | 3.165 |
| August 11, 2026 | 2.739 |
| August 10, 2026 | 2.811 |
| August 07, 2026 | 2.662 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.576 |
| Alnylam Pharmaceuticals, Inc. | 23.23 |
| Anika Therapeutics, Inc. | 1.989 |
| Savara, Inc. | 6.677 |
| Vericel Corp. | 5.594 |
Price to Book Value Related Metrics
| PEG Ratio | -0.3475 |
| Price | 20.75 |
| Earnings Yield | -22.00% |
| Market Cap | 399.13M |
| PEGY Ratio | -0.3475 |